Recent customer survey shows strong symptom relief among VagiVital® users
Stockholm, August 27[th] 2020 – Peptonic Medical (publ) (‘Peptonic’ or ‘Company’) today announced the results of a customer survey that was performed during spring/early summer this year among VagiVital users. It shows great user satisfaction and effective symptom relief. Of the nearly one hundred respondents, that had used VagiVital for one month or longer, 83 per cent reported symptom relief.- We are of course very pleased with this outcome, which confirms the results of past customer surveys and clinical studies. That is, VagiVital provides strong symptom relief to those women suffering